Every breakthrough, every milestone, and every step forward in 2025 had one thing in common: our community.
Because supporters like you showed up. You shared your story.
You asked others to stand with you.
And it mattered.
Here are just a few highlights from an extraordinary year:
-
The first-ever FDA-approved treatment for hyperphagia in PWS: VYKAT XR
-
FPWR’s first fully funded clinical trial nearing full enrollment: VNS4PWS
-
$2.1 million invested across 16 research projects advancing PWS and SYS science
This progress didn’t happen by accident. It happened because families refused to settle for “nothing can be done.” Because fundraisers turned effort into impact.
And because donors believed research could move faster, then made it happen.
One unstoppable community 👣
Because of you:
-
Research continues to accelerate
-
Clinical trials reach more families
-
New therapies come into focus
-
And hope feels closer than ever
From the bottom of our hearts, thank you.
Thank you for your time, your commitment, and your belief in this mission. Your support is making measurable progress possible for individuals and families affected by Prader-Willi syndrome and Schaaf-Yang syndrome.
As we close the chapter on 2025, we do so with deep gratitude and renewed resolve—to keep pushing research forward, to keep accelerating progress, and to keep showing up for every family who needs answers.
With sincere thanks,
The FPWR Team







